Nan Xiao
- Co-authors
- Jun GuoThomas A. RussoChao LiuPengcheng DuFansen JiZhiping WangRonald RodríguezJing Li
- Topics
- Liver Disease Diagnosis and Treatment (4 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Antibiotic Resistance in Bacteria (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Nan Xiao
12 papers receiving 280 citations
Peers
Comparison fields: 5 of 68
- Molecular Medicine 156
- Molecular Biology 93
- Epidemiology 76
- Hepatology 48
- Infectious Diseases 44
Countries citing papers authored by Nan Xiao
This map shows the geographic impact of Nan Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Xiao more than expected).
Fields of papers citing papers by Nan Xiao
This network shows the impact of papers produced by Nan Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Xiao. The network helps show where Nan Xiao may publish in the future.
Co-authorship network of co-authors of Nan Xiao
This figure shows the co-authorship network connecting the top 25 collaborators of Nan Xiao. A scholar is included among the top collaborators of Nan Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Xiao. Nan Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 16 | |
| 4 | Effect of radical resection combined with antiviral therapy in patients with hepatitis B virus-associated hepatocellular carcinoma and prognostic analysis. | 1 |
| 5 | 86 | |
| 6 | 24 | |
| 7 | 7 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | 9 | |
| 11 | 43 | |
| 12 | 5 | |
| 13 | 88 |
About Nan Xiao
Nan Xiao is a scholar working on Molecular Medicine, Hepatology and Applied Microbiology and Biotechnology, having authored 13 papers that have together received 287 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Molecular Medicine (156 citations), Applied Microbiology and Biotechnology (22 citations) and Endocrinology (42 citations). Nan Xiao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jun Guo, Thomas A. Russo, Chao Liu, Pengcheng Du, Fansen Ji, Zhiping Wang, Ronald Rodríguez, Jing Li, Junqiang Tian and Degui Wang. Their work appears in journals such as PLoS ONE, ACM Transactions on Graphics and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.